These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23447620)

  • 41. Differential activation of G-proteins by mu-opioid receptor agonists.
    Saidak Z; Blake-Palmer K; Hay DL; Northup JK; Glass M
    Br J Pharmacol; 2006 Mar; 147(6):671-80. PubMed ID: 16415903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
    Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential binding properties of oripavines at cloned mu- and delta-opioid receptors.
    Lee KO; Akil H; Woods JH; Traynor JR
    Eur J Pharmacol; 1999 Aug; 378(3):323-30. PubMed ID: 10493109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.
    Fan T; Varghese G; Nguyen T; Tse R; O'Dowd BF; George SR
    J Biol Chem; 2005 Nov; 280(46):38478-88. PubMed ID: 16159882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
    Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
    Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.
    Onoprishvili I; Simon EJ
    Brain Res; 2007 Oct; 1177():9-18. PubMed ID: 17897634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
    Sim LJ; Childers SR
    J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR; Clark MJ; Remmers AE
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell.
    Wang D; Surratt CK; Sadée W
    J Neurochem; 2000 Aug; 75(2):763-71. PubMed ID: 10899953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective interactions of mu-opioid receptors with pertussis toxin-sensitive G proteins: involvement of the third intracellular loop and the c-terminal tail in coupling.
    Georgoussi Z; Merkouris M; Mullaney I; Megaritis G; Carr C; Zioudrou C; Milligan G
    Biochim Biophys Acta; 1997 Dec; 1359(3):263-74. PubMed ID: 9434132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors.
    Borgland SL; Connor M; Osborne PB; Furness JB; Christie MJ
    J Biol Chem; 2003 May; 278(21):18776-84. PubMed ID: 12642578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.
    Porreca F; Tang QB; Bian D; Riedl M; Elde R; Lai J
    Brain Res; 1998 Jun; 795(1-2):197-203. PubMed ID: 9622629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor.
    Zhang D; Li JG; Chen C; Liu-Chen LY
    Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes.
    Celver JP; Lowe J; Kovoor A; Gurevich VV; Chavkin C
    J Biol Chem; 2001 Feb; 276(7):4894-900. PubMed ID: 11060299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
    Gray RE; Munks MW; Haynes RR; Olsen GD
    Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.
    Divin MF; Bradbury FA; Carroll FI; Traynor JR
    Br J Pharmacol; 2009 Apr; 156(7):1044-53. PubMed ID: 19220294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop.
    Bonner G; Meng F; Akil H
    Eur J Pharmacol; 2000 Sep; 403(1-2):37-44. PubMed ID: 10969141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
    Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
    J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.